Pure Global

BALVERSA 5 MG FILM COATED TABLET, 28 PCS - Turkey License b021875e39db7b5f86ff33c117e02424

Access comprehensive regulatory information for BALVERSA 5 MG FILM COATED TABLET, 28 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number b021875e39db7b5f86ff33c117e02424 with license number 2022/598and contains active ingredient Erdafitinib . The license is held by JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
b021875e39db7b5f86ff33c117e02424
License Details
Turkey SFDA License: b021875e39db7b5f86ff33c117e02424
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

BALVERSA 5 MG FILM COATED TABLET, 28 PCS
TR: BALVERSA 5 MG FİLM KAPLI TABLET, 28 ADET
Pharmaceutical Product

License Details

b021875e39db7b5f86ff33c117e02424

2022/598

8699593095665

L01EN01

License Holder Information

Active Ingredient

Erdafitinib

License Information

Oct 18, 2022